Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International Corporation insider filed a notice of proposed stock sales under Rule 144. The filing covers up to 15,000 shares of common stock to be sold through UBS Financial Services on or around
The shares relate to restricted stock units that vested on
Champlain Investment Partners, LLC reported beneficial ownership of 488,359 shares of Standex International common stock, representing 4.0% of the class as of September 30, 2025. Champlain has sole voting power over 308,124 shares and sole dispositive power over all 488,359 shares.
The firm certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Standex International, nor in connection with any transaction aimed at that purpose.
A shareholder of SXI has filed a notice of intent to sell 2,000 shares of common stock through The Charles Schwab Corporation on the NYSE. The shares have an indicated aggregate market value of $519,640.00, with the sale expected around February 9, 2026.
The filing shows these shares were acquired via restricted stock awards from the issuer as equity compensation on October 28, 2011 and October 25, 2025. The shareholder also represents that they are not aware of undisclosed material adverse information about the company’s operations.
Standex International Corporation director Thomas E. Chorman reported a small planned sale of company stock. On February 4, 2026, he sold 50 shares of common stock at a price of $249.86 per share under an existing Rule 10b5-1 trading plan dated November 6, 2025.
After this transaction, Chorman beneficially owned 13,179 shares of Standex common stock, held directly in his name.
Standex International Corporation filed a current report to furnish its second-quarter earnings news. The company states that it issued a press release announcing financial results for the quarter ended December 31, 2025, and has attached this release as an exhibit.
The press release, dated January 29, 2026, is provided as Exhibit 99 and is incorporated by reference. The filing is made under Item 2.02, which covers results of operations and financial condition, and includes standard cautionary language about forward-looking statements and related risk factors.
Standex International Corporation director Andy L. Nemeth reported buying additional company stock. On February 4, 2026, he purchased 2,000 shares of Standex common stock at a price of $245 per share. After this open-market purchase, he directly owns 8,639 shares of Standex common stock.
SXI insider Thomas Chorman has filed a Form 144 notice to sell common stock. The filing covers a planned sale of 50 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $12,493 and an approximate sale date of February 4, 2026.
The shares to be sold were acquired on October 26, 2024 through restricted stock vesting as compensation from the issuer. The filing also notes that Chorman sold 1,000 common shares on November 20, 2025 for gross proceeds of $223,310.10 during the prior three months.
Standex International delivered strong top-line growth for the quarter ended December 31, 2025. Net sales rose to $221,320 thousand from $189,814 thousand, lifting gross profit to $92,233 thousand. For the six-month period, net sales increased to $438,751 thousand from $360,278 thousand.
Income from operations improved sharply to $35,573 thousand for the quarter and $65,206 thousand year-to-date, compared with $8,463 thousand and $32,562 thousand in the prior-year periods. However, higher interest expense and a large increase in earnings attributable to redeemable noncontrolling interests limited net income attributable to common stockholders to $2,120 thousand for the quarter and $17,175 thousand for six months.
Cash from operating activities grew to $37,384 thousand from $26,631 thousand, while long-term debt declined to $534,733 thousand. Results also reflect recent acquisitions, including McStarlite and the Amran/Narayan Group, which added goodwill and significant customer-related intangible assets.
Standex International Corporation filed Amendment No. 2 to its 2025 annual report to add a missing exhibit for its Compensation Clawback Policy. The company explains that the policy, adopted on August 15, 2023 and already available on its website, was inadvertently left off the original exhibit list and is now included as Exhibit 97. No other parts of the 2025 annual report are updated or changed, and the original report remains applicable as of its original filing date.
Standex International Corporation director reports share transfer to family trust. On 12/26/2025, a director of Standex International Corporation moved 1,295 shares of common stock from direct ownership to indirect ownership as trustee of the Cannon Family Trust, using transaction code G, which indicates a gift or similar transfer. After the transaction, the director held 2,280 shares directly and 15,046 shares indirectly as trustee, reflecting a change in how the shares are held rather than a purchase or sale in the open market.